Trademark Overview
On Friday, December 13, 2024, a trademark application was filed for LENIUXIN with the United States Patent and Trademark Office. The USPTO has given the LENIUXIN trademark a serial number of 98902614. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, December 14, 2024. The LENIUXIN trademark is filed in the Pharmaceutical Products category with the following description:
Hormones; Dietary food supplements; Gummy vitamins; Health food supplements; Natural supplements for treating candida; Nutritional supplement for eliminating toxins from the intestinal tract; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Vitamin supplements; Weight management supplements
